ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3  (02-2018)

Period of time： 2018年3期

Publisher： John Wiley & Sons Inc

Founded in： 1987

Total resources： 82

E-ISSN： 1365-2036|47|3

ISSN： 0269-2813

Subject： R Medicine and Health

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3

Menu

Issue Information

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3 , Vol. 47, Iss. 3, 2018-02 , pp. 315-317

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Systematic review with meta‐analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3 , Vol. 47, Iss. 3, 2018-02 , pp. 318-331

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3 , Vol. 47, Iss. 3, 2018-02 , pp. 332-345

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Anti‐infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3 , Vol. 47, Iss. 3, 2018-02 , pp. 346-355

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12‐month multicentre observational prospective cohort study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3 , Vol. 47, Iss. 3, 2018-02 , pp. 356-363

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Market share and costs of biologic therapies for inflammatory bowel disease in the USA

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3 , Vol. 47, Iss. 3, 2018-02 , pp. 364-370

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

The long‐term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3 , Vol. 47, Iss. 3, 2018-02 , pp. 371-379

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication ‐ a prospective study for up to 10 years

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3 , Vol. 47, Iss. 3, 2018-02 , pp. 380-390

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Regional gastrointestinal contractility parameters using the wireless motility capsule: inter‐observer reproducibility and influence of age, gender and study country

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3 , Vol. 47, Iss. 3, 2018-02 , pp. 391-400

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Sofosbuvir and daclatasvir therapy in patients with hepatitis C‐related advanced decompensated liver disease (MELD ≥ 15)

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 3 , Vol. 47, Iss. 3, 2018-02 , pp. 401-411

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Previous 1 2 3 Next Display item(s) per page Total 27 item(s)